These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30588836)

  • 1. The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?
    Nobili V; Alisi A; Mosca A; Crudele A; Zaffina S; Denaro M; Smeriglio A; Trombetta D
    Antioxid Redox Signal; 2019 Jul; 31(2):127-133. PubMed ID: 30588836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
    Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
    Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
    Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
    Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
    Panera N; Braghini MR; Crudele A; Smeriglio A; Bianchi M; Condorelli AG; Nobili R; Conti LA; De Stefanis C; Lioci G; Gurrado F; Comparcola D; Mosca A; Sartorelli MR; Scoppola V; Svegliati-Baroni G; Trombetta D; Alisi A
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
    El Amrousy D; Abdelhai D; Shawky D
    Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease.
    Alberti G; Gana JC; Santos JL
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33212947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
    Polyzos SA; Kountouras J; Anastasilakis AD; Makras P; Hawa G; Sonnleitner L; Missbichler A; Doulberis M; Katsinelos P; Terpos E
    Hormones (Athens); 2018 Dec; 17(4):573-579. PubMed ID: 30467685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
    J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Bril F; Biernacki DM; Kalavalapalli S; Lomonaco R; Subbarayan SK; Lai J; Tio F; Suman A; Orsak BK; Hecht J; Cusi K
    Diabetes Care; 2019 Aug; 42(8):1481-1488. PubMed ID: 31332029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
    Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vitamin E in nonalcoholic fatty liver disease.
    Nagashimada M; Ota T
    IUBMB Life; 2019 Apr; 71(4):516-522. PubMed ID: 30592129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of thymol and vitamin E on nonalcoholic fatty liver disease in male Wistar rats.
    Lahmi A; Oryan S; Eidi A; Rohani AH
    Braz J Biol; 2023; 84():e268781. PubMed ID: 36629640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial.
    Al-Baiaty FDR; Ishak S; Mohd Zaki F; Masra F; Abdul Aziz DA; Wan Md Zin WN; Yee Hing E; Kuthubul Zaman AS; Abdul Wahab N; Muhammad Nawawi KN; Hamid Z; Raja Ali RA; Mokhtar NM
    BMC Pediatr; 2024 Aug; 24(1):529. PubMed ID: 39160468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M
    J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
    Della Corte C; Carpino G; De Vito R; De Stefanis C; Alisi A; Cianfarani S; Overi D; Mosca A; Stronati L; Cucchiara S; Raponi M; Gaudio E; Byrne CD; Nobili V
    PLoS One; 2016; 11(12):e0168216. PubMed ID: 27977757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
    Zöhrer E; Alisi A; Jahnel J; Mosca A; Della Corte C; Crudele A; Fauler G; Nobili V
    Appl Physiol Nutr Metab; 2017 Sep; 42(9):948-954. PubMed ID: 28511023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
    Sharifi N; Amani R; Hajiani E; Cheraghian B
    Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.